Bozhevolnyi SI, Volkov VS, Devaux E, Laluet JY, Ebbesen TW: Chann

Bozhevolnyi SI, Volkov VS, Devaux E, Laluet JY, Ebbesen TW: Channel plasmon subwavelength waveguide components including interferometers and ring resonators. Nature 2006, 440:508–511.CrossRef 6. Bian YS, Zheng Z, Zhao X, Su YL, Liu L, Liu JS, Zhu JS, Zhou T: Highly confined hybrid QNZ supplier plasmonic modes guided by nanowire-embedded-metal

grooves for low-loss propagation at 1,550 nm. IEEE J Sel Topics Quantum Electron 2013, 19:4800106.CrossRef 7. Quinten M, Leitner A, Krenn JR, Aussenegg FR: Electromagnetic energy transport via linear chains of silver nanoparticles. Opt Lett 1998, 23:1331–1333.CrossRef 8. Burke JJ, Stegeman GI: Surface-polariton-like waves guided by thin, lossy metal films. Phys Rev B 1986, 33:5186–5201.CrossRef 9. Manjacavas A, de Aabajc FJ G: Robust plasmon waveguides in strongly PF-3084014 concentration interacting nanowire arrays. Nano Lett 2009, 9:1285–1289.CrossRef 10. Zhang ZX, Hu ML, Chan KT, Wang CY: Plasmonic waveguiding in a hexagonally ordered metal wire array. Opt Lett 2010, 35:3901–3903.CrossRef 11. Wei W, Zhang X, Yu H, Huang YQ, Ren XM: Plasmonic waveguiding properties of the gap plasmon mode with a dielectric substrate. Photon Nano Fund Appl 2013, 11:279–287.CrossRef 12. Chen L, Li X, Wang GP, Li W, Chen SH, Xiao L, Gao DS: A silicon-based 3-D hybrid long-range plasmonic waveguide for nanophotonic integration. J Lightw Tech 2012, 30:163–168.CrossRef 13. Zayats AV, Smolyaninov II,

Maradudin AA: Nano-optics of surface plasmon polaritons. Phys Rep 2005, 408:131–314.CrossRef 14. Oulton RF, Sorger VJ, Genov DA, Pile Inositol monophosphatase 1 DFP, Zhang X: A hybrid plasmonic waveguide for subwavelength confinement and long-range propagation. Nat Photon 2008, 2:496–500.CrossRef 15. Bian YS, Zheng Z, Zhao X, Zhu JS, Zhou T: Symmetric hybrid surface plasmon polariton waveguides for 3D photonic integration. Opt Express 2009, 17:21320–21325.CrossRef 16. Chen JJ, Zhi L, Yue S, Gong QH: Hybrid long-range surface plasmon-polariton modes with tight field confinement guided by asymmetrical waveguide. Opt Express 2009, 17:23603–23609.CrossRef 17. Cai GX, Luo M, Xu HY, Liu QH: A slot-based surface plasmon-polariton waveguide with long-range

propagation and superconfinement. IEEE Photon J 2012, 4:844–855.CrossRef 18. Chen L, Zhang T, Li X, Huang WP: Novel hybrid plasmonic waveguide consisting of two identical dielectric nanowires symmetrically placed on each side of a thin metal film. Opt Express 2012, 20:20535–20544.CrossRef 19. Bian YS, Gong QH: Low-loss light transport at the subwavelength scale in silicon nano-slot based symmetric hybrid plasmonic waveguiding schemes. Opt Express 2013, 21:23907–23920.CrossRef 20. Chen L, Li X, Wang GP: A hybrid long-range plasmonic waveguide with sub-wavelength confinement. Opt Commun 2013, 291:400–404.CrossRef 21. Sun R, Dong P, Feng N, Hong C, Michel J, Lipson M, Kimerling L: Horizontal single and multiple slot waveguides: optical transmission at λ = 1,550 nm. Opt Express 2007, 15:17967–17972.CrossRef 22.

Conclusions Pets are members

Conclusions Pets are members

17DMAG research buy of the North American family, with 37% of American and 33% of Canadian households containing pet dogs [25, 26]. As our understanding of Campylobacter pathogenicity increases, so must our understanding of its reservoirs and ecology. Domestic dogs are recognized as a risk factor for campylobacteriosis and this report reinforces those findings. We found human pathogens like C. jejuni, C. coli, C. upsaliensis, C. gracilis, C. concisus and C. showae in dog feces, with significantly higher levels present in dogs with diarrhea. As well, we see that disturbances to the intestinal microbiota related to diarrhea have an effect on Campylobacter ecology. How and why this is the case, as well as how this change in Campylobacter distribution relates to the overall intestinal community, are areas of future

investigation. Methods Sample Collection Fecal samples from healthy dogs were submitted for analysis by pet owners from the Saskatoon, SK, Canada metropolitan area (population 250,000) (Additional file 1: Table S1). All dogs were considered healthy by their owners and had not received antibiotic therapy for at least six months prior to sample collection. Samples were collected in accordance with the University of Saskatchewan Animal Research Ethics Board (protocol #20090054). Fecal specimens from dogs suffering from diarrhea (of any etiology) were obtained from samples submitted to Prairie Diagnostic Services click here Inc., Saskatoon, SK for routine bacteriology Uroporphyrinogen III synthase and/or parasitology

testing (Additional file 1: Table S1). All samples were stored at -80°C until processed for PCR analysis. DNA Extraction Total bacterial DNA was extracted from fecal samples using the QIAamp DNA stool kit (Qiagen), as per manufacturer’s instructions. Final DNA samples were diluted 1:10 with sterile water before analysis. This was done to improve the overall sensitivity of the assays used, which are known to be affected by PCR inhibitors carried through fecal DNA extractions [21]. Quantitative PCR (qPCR) The detection and quantification of the 14 species of Campylobacter reported was done using assays targeting the cpn60 gene using the primer sets and PCR conditions described in [21]. The lower detection limit of these assays is 103 copies/g of feces [21]. Total bacterial DNA levels were measured by quantification of the 16S rRNA gene, using the primer set SRV3-1/SRV3-2 (with an annealing temperature of 62°C) described in [27]. All assay reaction mixtures consisted of 1× iQ SYBR green supermix (Bio-Rad), 400 nmol/L concentrations of each of the appropriate primers, and 2 μL of template DNA in a final volume of 25 μL.

Accordingly, pentoses such as ribose are known to form stable bor

Accordingly, pentoses such as ribose are known to form stable borate complexes. The binding preferences of borate to pentoses has been determined to be ribose > lyxose > arabinose > xylose (Li, 2005). The ribose molecule may be stabilized by borate that binds to the 2′ and 3′ positions of the furanose form of ribose. The fact that ribose is stabilized by borate Brigatinib cell line may change our opinion of the formose reaction as a seemingly random and nonselective reaction into a very precise geochemical pre-RNA process. The formose reaction was, for a while, an outdated concept for abiotic synthesis of carbohydrates. However, because of borate complex formation it is still possible

that it is responsible for prebiotic formation of ribose in natural environments and that this may occur in close vicinity to abiotic purine synthesis and phosphorylation processes in alkaline hydrothermal environments of convergent margins. Once pyrophosphate is available, phosphorylation of ribose and/or nucleosides may occur. Li, Q., Ricardo, A., Benner, S.A., Winefordner, J.D., and Powell, D.H. (2005). Desorption/ionization on porous silicon mass spectrometry studies on pentose–borate complexes. Analytical Chemistry 77, 4503–4508. E-mail: nils.​holm@geo.​su.​se Models of Abiotic Synthesis of Adenosine Mono-, Doramapimod research buy Di- and Triphosphate Taisiya A. Telegina, Michael P. Kolesnikov, Mikhail S. Kritsky A.N. Bach Institute of Biochemistry, Russian Academy of Sciences,

Moscow, Russia The first step of ATP synthesis, i.e. the de novo formation of 5′-AMP molecule, is achieved in organisms via a multistage enzymatic process in which adenine heterocycle is built up on the ribose-5-phosphate pedestal from C and N atoms originating from formic acid, carbon dioxide, glutamine, glycine and aspartic acid. We showed that under abiotic conditions

5′-AMP can be formed from the same precursors, i.e. the mixture of ribose, potassium phosphate, sodium bicarbonate, ammonium formate, glutamine, glycine and aspartic acid. After 40 min incubation of anhydrous mixture of these compounds at 85°C in oxygen-free atmosphere, 5′-AMP was identified among reaction products by using HPLC for isolation of this nucleotide. The phosphorylation of this nucleotide product gave rise to ATP which was detected by a highly specific luciferin-luciferase luminescence Rebamipide test. The yield of 5′-AMP (calculated to initial ribose content) was about 3–5%. The efficiency of the same set of chemical precursors for abiotic and biological synthesis of 5′-AMP is of interest in context of the development of metabolic pathway of purine nucleotides biosynthesis in early stages of evolution. According to results of laboratory modeling, in prebiotic world there existed various options for photon energy conservation in energy rich phosphoanhydride bonds of ADP and ATP including the photophosphorylation processes, which did not need any organic sensitizers.

System Appl Microbiol 1997, 20:173–181 47 Miller JH: A Short Co

System Appl Microbiol 1997, 20:173–181. 47. Miller JH: A Short Course in Bacterial Genetics. Cold Spring Harbor, NY: Cold Spring

Harbor Laboratory; 1992. 48. Csonka LN: A third L-proline permease in Salmonella typhimurium which functions in media of elevated osmotic strength. J Bacteriol 1982, 151:1433–1443.PubMed 49. Simon R, Priefer U, Pühler A: A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria. Biotechnology 1983, 1:784–791.CrossRef 50. Prentki P, Krisch HM: In vitro insertional mutagenesis click here with a selectable DNA fragment. Gene 1984, 29:303–313.PubMedCrossRef 51. Blondelet-Rouault MH, Weiser J, Lebrihi A, Branny P, Pernodet JL: Antibiotic resistance gene cassettes derived from the π interposon for use in E. coli and Streptomyces . Gene 1997, 190:315–317.PubMedCrossRef 52. Quandt J, Hynes MF: Versatile

suicide vectors which allow direct selection for gene replacement in gram-negative bacteria. Gene 1993, 127:15–21.PubMedCrossRef 53. Jebbar M, Talibart R, Gloux K, Bernard T, Blanco C: Osmoprotection of Escherichia coli by ectoine: uptake and accumulation characteristics. J Bacteriol 1992, 174:5027–5035.PubMed 54. Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596–1599.PubMedCrossRef selleck chemicals 55. Saitou N, Nei M: The Neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406–425.PubMed 56. Felsenstein J: Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985, 39:783–791.CrossRef

57. Schultz J, Milpetz F, Bork P, Ponting CP: SMART, a simple modular architecture research tool: Edoxaban Identification of signaling domains. Proc Natl Acad Sci USA 1998, 95:5857–5864.PubMedCrossRef 58. Letunic I, Doerks T, Bork P: SMART 6: recent updates and new developments. Nucleic Acids Res 2009, 37:D229-D232.PubMedCrossRef 59. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:D277–280.PubMedCrossRef 60. Hulo N, Bairoch A, Bulliard V, Cerutti L, Cuche B, De Castro E, Lachaize C, Langendijk-Genevaux PS, Sigrist CJA: The 20 years of PROSITE. Nucleic Acids Res 2008, 36:D245-D249.PubMedCrossRef 61. Henikoff JG, Pietrokovski S, McCallum CM, Henikoff S: Blocks-based methods for detecting protein homology. Electrophoresis 2000, 21:1700–1706.PubMedCrossRef 62. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunesekaran P, Ceric G, Forslund K, Holm L, Sonnhammer EL, Eddy SR, Bateman A: The Pfam protein families database. Nucleic Acids Res 2010, 38:D211–222.PubMedCrossRef 63. Zdobnov EM, Apweiler R: InterProScan – an integration platform for the signature-recognition methods in InterPro. Bioinformatics 2001, 17:847–848.PubMedCrossRef 64. Käll L, Krogh A, Sonnhammer ELL: A Combined Transmembrane Topology and Signal Peptide Prediction Method.

Taraporewala Z, Chen

Taraporewala Z, Chen IWR-1 ic50 D, Patton JT: Multimers formed by the rotavirus nonstructural protein NSP2 bind to RNA and have nucleoside triphosphatase activity. J Virol 1999, 73:9934–9943.PubMed 3. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI: Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998, 279:1371–1376.CrossRefPubMed 4. Muller H, Johne R: Rotaviruses: diversity and zoonotic potential–a brief review. Berl Munch Tierarztl Wochenschr 2007, 120:108–112.PubMed 5. Matthijnssens J, Ciarlet M, Heiman E, Arijs I, Delbeke T, McDonald SM, Palombo EA, Iturriza-Gómara

M, Maes P, Patton J, Rahman M, Van Ranst M: Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol 2008, 82:3204–3219.CrossRefPubMed 6. Matthijnssens J, Ciarlet M, Rahman M, Attoui H, Banyai K, Estes MK, Gentsch JR, Iturriza-Gùomara M, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Patton JT, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Desselberger I, Van Ranst M: Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol 2008, 153:1621–1629.CrossRefPubMed 7. Larkin MA, Blackshields G, Brown NP,

Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG: Clustal W and Sirolimus cell line Clustal X version 2.0. Bioinformatics

2007, 23:2947–2948.CrossRefPubMed 8. Needleman SB, Wunsch selleck chemicals CD: A general method applicable to the search for similarities in the amino acid sequence of two proteins. J Mol Biol 1970, 48:443–453.CrossRefPubMed 9. Wilgenbusch JC, Swofford D: Inferring evolutionary trees with PAUP*. Curr Protoc Bioinformatics 2003, Chapter 6:Unit 6.4.PubMed 10. Rahman M, Matthijnssens J, Yang X, Delbeke T, Arijs I, Taniguchi K, Itturiza-Gómara M, Iftekharuddin N, Azim T, Van Ranst M: Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol 2007, 81:2382–2390.CrossRefPubMed 11. Matthijnssens J, Rahman M, Yang X, Delbeke T, Arijs I, Kabue JP, Muyembe JJ, Van Ranst M: G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1-like genogroup. J Clin Microbiol 2006, 44:1801–1809.CrossRefPubMed 12. Desselberger U, Iturriza-Gomara M, Gray JJ: Rotavirus epidemiology and surveillance. Novartis Found Symp 2001, 238:125–147.CrossRefPubMed 13. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Tatusova T: FLAN: a web server for influenza virus genome annotation. Nucleic Acids Res 2007, 35:W280-W284.CrossRefPubMed 14. Kuiken C, Yusim K, Boykin L, Richardson R: The Los Alamos hepatitis C sequence database. Bioinformatics 2005, 21:379–384.CrossRefPubMed 15. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T: A web-based genotyping resource for viral sequences. Nucleic Acids Res 2004, 32:W654-W659.CrossRefPubMed 16.

Proc Soc Exp Biol Med 1987, 124:360–366 58 Fries CSA, Jeffery S

Proc Soc Exp Biol Med 1987, 124:360–366. 58. Fries CSA, Jeffery SLA, Kay AR: Topical negative pressure and military wounds-A review of the evidence. Injury, Int J care Injured 2011, 42:436–440. 59. Leininger BE, Rasmussen TE, Smith DL: Experience with wound VAC and delay primary closure of contaminated soft tissue injuries in Iraq. J Trauma 2006,61(5):1207–1211.PubMedCrossRef selleck 60. Mathes SJ, Steinwald PM, Foster RD, Hoffman WY, Anthony JP: Complex abdominal wall reconstruction: A comparison of flap and mesh closure. Ann Surg 2000,232(4):586–596.PubMedCrossRef 61. Ramirez OM, Ruas E, Dellon AL: “”Component

separation”" method for closure of abdominal wall defect: An anatomic and clinical study. Plast Reconst Surg 1990,86(3):519–526.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions All authors participated in the design

of the paper, conceived the paper, and participated in drafting and critical revision for important intellectual content. All authors read and approved the final form of this manuscript.”
“Introduction Human injury resulting from encounters with non-domesticated animals is increasingly common throughout the world, particularly as ecosystems change and humans encroach on previously wild land [1]. Though the management of injuries resulting from dog bites, zoo animal attacks, and trampling selleck kinase inhibitor or kicking by large mammals such as cows, moose, or deer, is facilitated by well-developed emergency response systems in the western world [2], more unusual wild animal attacks and the complex injuries that result may pose a challenge to surgeons practicing in resource-limited settings. Further, many reports of these attacks in Africa are drawn from the lay press and associated with

tourist activity, and much less Orotic acid is written to guide management of injuries suffered by local populations during activities of daily living [3]. Given the populous nature of bush animals throughout the rural northwestern Tanzania region of Lake Victoria, Lake Tanganyika, and the Serengeti National Park, and the increasingly frequent human encounters with them, there is new need to document attacks, patient management, and outcomes. While local health care systems may be familiar with triaging common dog and snake bites, guidance regarding the management of larger and more unusual bush animals is lacking. We believe that utilizing basic trauma survey principles, infection control, and necessary surgical management can provide appropriate outcomes in resource-limited settings. Materials and methods Four patients with wild animal attacks who presented in 2010-11 to the northwestern Tanzania tertiary referral hospital, Bugando Medical Centre (BMC), were documented.

Third, the pathological stage data in some studies were from biop

Third, the pathological stage data in some studies were from biopsy not radical prostatectomy specimens. Last but not least, to date there remains limited studies focusing on this association, although many of the available studies are well designed case-control or longitudinal cohort studies. In addition to the limitations listed above, another limitation for the analyses of the association between MetS and prostate cancer risk or prostate cancer parameters is that we did not perform a meta-regression to attempt to explain the heterogeneity

of the study because Cell Cycle inhibitor of the varying adjustments in the individual studies. The result of a recent meta-analysis on 9 cross-sectional studies of metabolic syndrome in adult cancer survivors increases the weight of this suspicion, as it revealed that no significant association was found for non-hematologic malignancies, including testicular tumor, prostate cancer, sarcoma, and epithelial ovarian [45]. Therefore, there is an urgent future need to confirm this association and to find potential mechanisms to explain how metabolic factors affect the development or progression of Lorlatinib PCa. Conclusions Based on the current findings,

MetS is not associated with prostate cancer risk, but preliminary evidences demonstrates that men with MetS more frequently suffer high-grade prostate cancer, more advanced disease and are at greater risk of progression after radical prostatectomy and prostate cancer-specific death. Together, these findings indicate

that MetS may be associated with the progression of prostate cancer and adverse clinical outcomes. Tolmetin Further studies with adjustment for appropriate confounders and larger, prospective, multicenter investigations are required in the future. Acknowledgments The authors thank Dina A Yousif from department of Medcine, Vanderbilt University, USA for checking the English language of the manuscript. Funding This study was supported by China Scholarship Council (NO: 2009622110) and National Science Fund for Distinguished Young Scholars (NO: 81202016). References 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011,61(2):69–90.PubMedCrossRef 2. Siegel R, Ward E, Brawley O, Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011,61(4):212–236.PubMedCrossRef 3. Nelson WG, De Marzo AM, Isaacs WB: Prostate cancer. N Engl J Med 2003,349(4):366–381.PubMedCrossRef 4. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988,37(12):1595–1607.PubMedCrossRef 5.

Anticancer Res 1989, 9:215–223 PubMed 34 D’Agostino L, Pignata S

Anticancer Res 1989, 9:215–223.PubMed 34. D’Agostino L, Pignata S, Daniele B, D’Adamo G, Ferraro C, Silvestro G, Tagliaferri P, Contegiacomo A, Gentile R, Tritto G, et al.: Polyamine

uptake by human colon carcinoma cell line CaCo-2. Digestion 1990,46(Suppl 2):352–359.PubMed 35. Feige JJ, Chambaz EM: Polyamine uptake by bovine adrenocortical cells. Biochim Biophys Acta 1985, 846:93–100.PubMed 36. Cooper KD, Shukla JB, Rennert OM: Polyamine compartmentalization in various human disease Aloxistatin states. Clin Chim Acta 1978, 82:1–7.PubMed 37. Upp JR Jr, Saydjari R, Townsend CM Jr, Singh P, Barranco SC, Thompson JC: Polyamine levels and gastrin receptors in colon cancers. Ann Surg 1988, 207:662–669.PubMed 38. Hixson LJ, Garewal HS, McGee DL, Sloan D, Fennerty MB, Sampliner RE, Gerner

EW: Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa. Cancer Epidemiol Biomarkers Prev 1993, 2:369–374.PubMed 39. Osborne DL, Seidel ER: Gastrointestinal luminal polyamines: cellular accumulation and enterohepatic circulation. Am J Physiol 1990, 258:G576–584.PubMed 40. Kobayashi M, Xu YJ, Samejima K, Goda H, Niitsu M, Takahashi M, Hashimoto Y: Fate of orally administered 15N-labeled polyamines in rats bearing solid tumors. Biol Pharm Bull 2003, 26:285–288.PubMed 41. Soda K, Kano Y, Nakamura T, Kasono K, Kawakami M, Konishi F: Spermine, a natural polyamine, suppresses LFA-1 expression on human lymphocyte. J Immunol 2005, 175:237–245.PubMed 42. Kano Y, Soda K, Nakamura T, Saitoh M, Kawakami M, Konishi F: Increased blood spermine levels decrease the cytotoxic activity Astemizole of lymphokine-activated Ceritinib ic50 killer cells: a novel mechanism of cancer evasion. Cancer Immunol Immunother 2007, 56:771–781.PubMed 43. Klein S, Miret JJ, Algranati ID, de Lustig ES: Effect of alpha-difluoromethylornithine in lung metastases before and after surgery of primary adenocarcinoma tumors in mice. Biol Cell 1985, 53:33–36.PubMed 44. Herr HW, Kleinert EL, Conti PS, Burchenal JH, Whitmore WF Jr: Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the

growth of experimental renal adenocarcinoma in mice. Cancer Res 1984, 44:4382–4385.PubMed 45. Luk GD, Abeloff MD, Griffin CA, Baylin SB: Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice. Cancer Res 1983, 43:4239–4243.PubMed 46. Kingsnorth AN, McCann PP, Diekema KA, Ross JS, Malt RA: Effects of alpha-difluoromethylornithine on the growth of experimental Wilms’ tumor and renal adenocarcinoma. Cancer Res 1983, 43:4031–4034.PubMed 47. Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, et al.: Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001, 49:71–77.PubMed 48.